Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Haemonetics Corporation (NYSE: HAE ) stock surged Thursday after the company disclosed that CSL Plasma Inc. plans to deploy its NexSys PCS devices with Persona PLUS technology across all its current U.S. plasma collection centers by the end of 2027. The planned rollout marks a significant expansion of the company’s sup
Haemonetics said CSL Plasma plans to adopt its plasma collection equipment across all of its existing U.S. collection centers, with the rollout expected to finish by December 2027. The company kept its fiscal 2027 guidance unchanged because the timing and financial impact remain uncertain.